This post was presented to the Carleton University Disability Research Group earlier this year and is cross-posted on their website.
By Jameel Hampton
Beginning with the recognition of the special needs of disabled schoolchildren in the 1880s, the British state took on the welfare of groups of disabled people perceived to be deserving of statutory welfare. Disabled ex-servicemen and blind people were recognized in legislation both during and after the First World War. The creation of the post-Second-World-War welfare state brought the possibility of new benefits in cash and services for all disabled people, but millions of disabled people were largely excluded, and remained a relatively ignored group throughout the 1950s.
With the “rediscovery of poverty” and the liberalization of British society in the 1960s, the welfare of disabled people emerged as an important political and policy issue. This breakthrough in recognition developed into small, targeted legislation in cash benefits in the early 1970s, as well as the landmark 1970 Chronically Sick and Disabled Persons Act. While disabled people appeared to have made great gains with the extensive cash benefits of 1974-1975, these benefits proved ineffective, and appeared just before the rolling back of the state and a renewed focus on non-statutory welfare. Perceptions of the welfare of disabled people changed greatly from 1940s to the 1970s, and while there were psychological and representative gains, policies during the post-Second-World-War welfare state did little to improve their welfare.
Thalidomide became available in Britain in 1958 under the name Distival. A sedative used to combat nausea in pregnant women, it was used until 1961 when links were made between its use and limb deformity. The British distributor of the drug, the Distillers Company, withdrew the drug from distribution in December 1961.
Approximately 400 children in Britain suffered deformities because of the drug. The tragedy led to procedures in Britain for the examination of new pharmaceuticals, as it did in many of the 46 countries where thalidomide was distributed. The Committee on the Safety of Drugs was established in 1963 to check the safety of new drugs for sale or clinical testing. The parents of thalidomide children fought a long court battle for compensation. In July 1969, Distillers eventually settled the claims by giving known victims £3.25million over 10 years: this equated to about £15,000 for the worst affected. Assessments at the time stated that victims with severe deformities would need at least £100,000 to cover their welfare throughout their lifetimes.
In September 1972, the Sunday Times began to publish a series of articles on compensation for thalidomide children detailing the efforts of Distillers to avoid paying any considerable compensation. Continue reading
